Sangamo Therapeutics Inc. (SGMO)
NASDAQ: SGMO
· Real-Time Price · USD
0.55
0.02 (3.73%)
At close: Sep 05, 2025, 3:59 PM
0.54
-1.32%
After-hours: Sep 05, 2025, 07:52 PM EDT
Sangamo Therapeutics Revenue
Sangamo Therapeutics reported an annual revenue of $57.8M, reflecting a -67.2% growth. For the quarter ending June 30, 2025, Sangamo Therapeutics generated $18.31M in revenue.
Revenue (ttm)
57.8M
Revenue Growth
-67.2%
Price / Sales Ratio
3.56
Revenue / Employee
315.85K
Employees
183
Market Cap
165.1M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 57.8M | -67.20% |
| Dec 31, 2023 | 176.23M | +58.34% |
| Dec 31, 2022 | 111.3M | +0.54% |
| Dec 31, 2021 | 110.7M | -6.34% |
| Dec 31, 2020 | 118.19M | +15.39% |
| Dec 31, 2019 | 102.43M | +21.29% |
| Dec 31, 2018 | 84.45M | +130.95% |
| Dec 31, 2017 | 36.57M | +88.60% |
| Dec 31, 2016 | 19.39M | -50.96% |
| Dec 31, 2015 | 39.54M | -13.80% |
| Dec 31, 2014 | 45.87M | +90.07% |
| Dec 31, 2013 | 24.13M | +11.44% |
| Dec 31, 2012 | 21.66M | +109.86% |
| Dec 31, 2011 | 10.32M | -50.40% |
| Dec 31, 2010 | 20.8M | -6.23% |
| Dec 31, 2009 | 22.19M | +37.08% |
| Dec 31, 2008 | 16.19M | +77.91% |
| Dec 31, 2007 | 9.1M | +15.38% |
| Dec 31, 2006 | 7.88M | +217.43% |
| Dec 31, 2005 | 2.48M | +88.90% |
| Dec 31, 2004 | 1.31M | -49.01% |
| Dec 31, 2003 | 2.58M | -40.62% |
| Dec 31, 2002 | 4.34M | -11.10% |
| Dec 31, 2001 | 4.88M | +42.30% |
| Dec 31, 2000 | 3.43M | +56.05% |
| Dec 31, 1999 | 2.2M | +7.95% |
| Dec 31, 1998 | 2.04M | +76.91% |
| Dec 31, 1997 | 1.15M | +82.28% |
| Dec 31, 1996 | 632K | n/a |